1. Home
  2. TSQ vs AGEN Comparison

TSQ vs AGEN Comparison

Compare TSQ & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TSQ

Townsquare Media Inc.

HOLD

Current Price

$5.06

Market Cap

110.8M

ML Signal

HOLD

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$3.35

Market Cap

126.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSQ
AGEN
Founded
1996
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.8M
126.2M
IPO Year
2000
2000

Fundamental Metrics

Financial Performance
Metric
TSQ
AGEN
Price
$5.06
$3.35
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
$12.50
$14.50
AVG Volume (30 Days)
72.0K
604.5K
Earning Date
11-10-2025
11-10-2025
Dividend Yield
15.53%
N/A
EPS Growth
N/A
N/A
EPS
1.14
N/A
Revenue
$438,695,000.00
$106,829,000.00
Revenue This Year
N/A
$67.15
Revenue Next Year
$1.59
N/A
P/E Ratio
$4.51
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.30
$1.38
52 Week High
$10.23
$7.34

Technical Indicators

Market Signals
Indicator
TSQ
AGEN
Relative Strength Index (RSI) 45.69 31.67
Support Level $5.13 $3.26
Resistance Level $5.34 $4.00
Average True Range (ATR) 0.25 0.25
MACD 0.04 -0.06
Stochastic Oscillator 44.16 30.49

Price Performance

Historical Comparison
TSQ
AGEN

About TSQ Townsquare Media Inc.

Townsquare Media Inc is a radio, digital media, entertainment, and digital marketing solutions company principally focused on being the premier local advertising and marketing solutions platform in small and mid-sized markets across the United States. It has three segments which are Subscription Digital Marketing Solutions, Digital Advertising, and Broadcast Advertising. It earns the majority of the revenue from the Broadcasting Advertising segment, which includes its local, regional, and national advertising products and solutions delivered via terrestrial radio broadcast. Its portfolio includes local media brands such as WYRK.com, WJON.com, and NJ101.5.com, and premier national music brands such as XXLmag.com, TasteofCountry.com, UltimateClassicRock.com, and Loudwire.com.

About AGEN Agenus Inc.

Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).

Share on Social Networks: